Mariela Alvarado Miranda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mariela Alvarado Miranda has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Esther Barreiro
Respiratory Department, Hospital del Mar de Barcelona; Hospital del Mar Research Institute, Barcelona; Department of Medicine and Life Sciences (MELIS), Pompeu Fabra University, Barcelona; Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Carlos III Institute of Health (ISCIII), Madrid
5 shared publicationsAntonio Sancho-Muñoz
Pulmonology Department, Scientific and Technical Department, Hospital del Mar-IMIM, CIBERES, UAB, UPF, Barcelona, Spain, Barcelona, Spain
4 shared publications- Ana Balañá Corberó
Department of Pulmonology, Hospital del Mar, Barcelona, Catalonia; Multidisciplinary ALS Unit, Hospital del Mar, Barcelona, Catalonia
3 shared publications - Diego Agustín Rodriguez-Chiaradia
Biomedical Research Networking Centre in Respiratory Diseases (CIBERES), 28029 Madrid, Spain
3 shared publications Joaquim Gea
Pulmonology Department-Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Hospital del Mar-IMIM (Parc de Salut Mar), Health and Experimental Sciences Department (DCEXS), Universitat Pompeu Fabra (UPF), Barcelona Biomedical Research Park (PRBB), Barcelona, Spain; Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos-III (ISCIII), Barcelona, Spain
3 shared publications- Juana Martínez Llorens
Department of Pulmonology, Hospital del Mar, Barcelona, Catalonia; Multidisciplinary ALS Unit, Hospital del Mar, Barcelona, Catalonia; Center for Research in Health and Economics, Pompeu Fabra University, Barcelona, Catalonia; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid
3 shared publications
Latest Publications
- Open Access
- 16 October 2025
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
Airway clearance techniques by video consultation for patients with bronchiectasis: satisfaction, adherence, effectiveness, and safety. A pilot study
Airway clearance techniques (ACT) should be included as part of the non-pharmacological treatment of patients with bronchiectasis (BE) following international guidelines. This approach in chronic respiratory patients should be maintained despite a pandemic situation, including SARS-CoV-2. The objective of this study is to evaluate the satisfaction, adherence, effectiveness, and safety of telehealth ACT (tACT) via video consultation for secretion drainage in patients with stable BE. This is an observational pilot study with prospective recruitment describing a cohort of patients with BE and patients with BE and infection due to non-tuberculous mycobacterial pulmonary disease (NTM-PD) included in a tACT program. Patients received an initial tACT visit (V1), another after one week (V7), and a final visit after one month (V30). Adherence, effectiveness and safety data were recorded. Satisfaction with the intervention was determined using a visual analogue scale (0-10). A total of 40 patients with BE and 17 patients with BE and NTM-PD were included, with a mean age of 63 (13). A total of 48 patients evaluated the telehealth intervention at >8 with the VAS, with a mean VAS score at V7 of 9.0 (1.9) and 8.9 (2) at V30. Self-reported adherence to treatment was high, with an average of 6.5/7 and 25/30 days; 94% of the patients managed to expectorate during V1 (effectiveness of the intervention). No relevant side effects were detected. tACT for managing secretions in patients with BE, whether with or without NTM-PD, has proven to be satisfactory, effective, and safe during a critical pandemic situation. This safety strategy could be included in the future as a complementary tool in the management of chronic respiratory patients.
- 16 October 2025
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
Open AccessAirway clearance techniques by video consultation for patients with bronchiectasis: satisfaction, adherence, effectiveness, and safety. A pilot study
Airway clearance techniques (ACT) should be included as part of the non-pharmacological treatment of patients with bronchiectasis (BE) following international guidelines. This approach in chronic respiratory patients should be maintained despite a pandemic situation, including SARS-CoV-2. The objective of this study is to evaluate the satisfaction, adherence, effectiveness, and safety of telehealth ACT (tACT) via video consultation for secretion drainage in patients with stable BE. This is an observational pilot study with prospective recruitment describing a cohort of patients with BE and patients with BE and infection due to non-tuberculous mycobacterial pulmonary disease (NTM-PD) included in a tACT program. Patients received an initial tACT visit (V1), another after one week (V7), and a final visit after one month (V30). Adherence, effectiveness and safety data were recorded. Satisfaction with the intervention was determined using a visual analogue scale (0-10). A total of 40 patients with BE and 17 patients with BE and NTM-PD were included, with a mean age of 63 (13). A total of 48 patients evaluated the telehealth intervention at >8 with the VAS, with a mean VAS score at V7 of 9.0 (1.9) and 8.9 (2) at V30. Self-reported adherence to treatment was high, with an average of 6.5/7 and 25/30 days; 94% of the patients managed to expectorate during V1 (effectiveness of the intervention). No relevant side effects were detected. tACT for managing secretions in patients with BE, whether with or without NTM-PD, has proven to be satisfactory, effective, and safe during a critical pandemic situation. This safety strategy could be included in the future as a complementary tool in the management of chronic respiratory patients.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA1072
Muscle phenotypic features in the vastus lateralis of patients with bronchiectasis
Objectives: In the vastus lateralis (VL) samples of control subjects and bronchiectasis (BQ) patients, we sought to study muscle phenotypic features including muscle regeneration muscle morphometry Methods: Ten healthy subjects and twenty stable BQ patients were recruited. Nutritional and functional parameters were evaluated. In the VL of the participants, muscle fiber type, morphometry, and structural abnormalities were assessed; apoptotic-nuclei were quantified using the TUNEL assay and counting techniques (conventional immunohistochemistry) and total numbers of satellite cells were measured through identification of markers Pax7 and Myf5 (conventional immunofluorescence with specific antibodies and fluorochromes). Results: Patients with BQ presented a reduction in nutritional and functional muscle parameters. The proportion of hybrid fibers was higher, and type II and hybrid fibers had smaller cross-sectional areas (CSA). Inner nuclei and TUNEL-positive nuclei proportions were increased in BQs. Quiescent cell (Pax7+/Myf5-) and total satellite cell counts were reduced. Conclusions: In the lower limb muscles of BQ patients, there are significant alterations in the muscle phenotype and metabolic features being the most relevant the presence of greater proportions of hybrid fibers and smaller cross-sectional areas of type II and hybrid fibers. Moreover, BQ patients presented muscle structural abnormalities mainly by a rise in the proportions of internal nuclei and apoptotic nuclei (TUNEL). Finally, patients presented an increase of activated satellite cells, which suggest the trigger of muscle regeneration. These findings will help elucidate the impact of BQ in the muscle physiology and function.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA1072
Muscle phenotypic features in the vastus lateralis of patients with bronchiectasis
Objectives: In the vastus lateralis (VL) samples of control subjects and bronchiectasis (BQ) patients, we sought to study muscle phenotypic features including muscle regeneration muscle morphometry Methods: Ten healthy subjects and twenty stable BQ patients were recruited. Nutritional and functional parameters were evaluated. In the VL of the participants, muscle fiber type, morphometry, and structural abnormalities were assessed; apoptotic-nuclei were quantified using the TUNEL assay and counting techniques (conventional immunohistochemistry) and total numbers of satellite cells were measured through identification of markers Pax7 and Myf5 (conventional immunofluorescence with specific antibodies and fluorochromes). Results: Patients with BQ presented a reduction in nutritional and functional muscle parameters. The proportion of hybrid fibers was higher, and type II and hybrid fibers had smaller cross-sectional areas (CSA). Inner nuclei and TUNEL-positive nuclei proportions were increased in BQs. Quiescent cell (Pax7+/Myf5-) and total satellite cell counts were reduced. Conclusions: In the lower limb muscles of BQ patients, there are significant alterations in the muscle phenotype and metabolic features being the most relevant the presence of greater proportions of hybrid fibers and smaller cross-sectional areas of type II and hybrid fibers. Moreover, BQ patients presented muscle structural abnormalities mainly by a rise in the proportions of internal nuclei and apoptotic nuclei (TUNEL). Finally, patients presented an increase of activated satellite cells, which suggest the trigger of muscle regeneration. These findings will help elucidate the impact of BQ in the muscle physiology and function.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA1078
Upper and lower limb muscle dysfunction in patients with bronchiectasis: the role of systemic inflammation and oxidative stress
Skeletal muscle dysfunction is common in many chronic respiratory diseases. Several clinical and biological factors contribute to its etiology. Acute exacerbations and systemic inflammation and oxidative stress are mostly responsible. Whether patients with bronchiectasis experience limb muscle dysfunction remains to be fully elucidated as well as the underlying mechanisms. In vastus lateralis (VL) of patients (n=20) with bronchiectasis and 10 healthy controls phenotypic features and in blood samples parameters of inflammation and oxidative stress were evaluated along with muscle function (upper and lower limbs). In bronchiectasis patients compared to controls, upper and lower limb muscle function and fast-twitch muscle fiber cross-sectional area were reduced, while systemic levels of myeloperoxidase, TGF-β1, VEGF-A, IL-6, protein carbonylation, superoxide dismutase activity, and reduced glutathione significantly increased. Muscle dysfunction of the upper and lower limbs in bronchiectasis patients is a relevant clinical feature, in which systemic inflammation and oxidative stress together with the predominance of a fast-twitch phenotype underlie its pathophysiology. These findings may have clinical implications when designing specific therapeutic strategies. Funding: FIS 21/00215 (FEDER, ISC-III), Intensificación INT19, CIBERES (ISC-III), SEPAR-2020.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA1078
Upper and lower limb muscle dysfunction in patients with bronchiectasis: the role of systemic inflammation and oxidative stress
Skeletal muscle dysfunction is common in many chronic respiratory diseases. Several clinical and biological factors contribute to its etiology. Acute exacerbations and systemic inflammation and oxidative stress are mostly responsible. Whether patients with bronchiectasis experience limb muscle dysfunction remains to be fully elucidated as well as the underlying mechanisms. In vastus lateralis (VL) of patients (n=20) with bronchiectasis and 10 healthy controls phenotypic features and in blood samples parameters of inflammation and oxidative stress were evaluated along with muscle function (upper and lower limbs). In bronchiectasis patients compared to controls, upper and lower limb muscle function and fast-twitch muscle fiber cross-sectional area were reduced, while systemic levels of myeloperoxidase, TGF-β1, VEGF-A, IL-6, protein carbonylation, superoxide dismutase activity, and reduced glutathione significantly increased. Muscle dysfunction of the upper and lower limbs in bronchiectasis patients is a relevant clinical feature, in which systemic inflammation and oxidative stress together with the predominance of a fast-twitch phenotype underlie its pathophysiology. These findings may have clinical implications when designing specific therapeutic strategies. Funding: FIS 21/00215 (FEDER, ISC-III), Intensificación INT19, CIBERES (ISC-III), SEPAR-2020.
- Open Access
Nitrosative and Oxidative Stress, Reduced Antioxidant Capacity, and Fiber Type Switch in Iron-Deficient COPD Patients: Analysis of Muscle and Systemic Compartments
We hypothesized that a rise in the levels of oxidative/nitrosative stress markers and a decline in antioxidants might take place in systemic and muscle compartments of chronic obstructive pulmonary disease (COPD) patients with non-anemic iron deficiency. In COPD patients with/without iron depletion (n = 20/group), markers of oxidative/nitrosative stress and antioxidants were determined in blood and vastus lateralis (biopsies, muscle fiber phenotype). Iron metabolism, exercise, and limb muscle strength were assessed in all patients. In iron-deficient COPD compared to non-iron deficient patients, oxidative (lipofuscin) and nitrosative stress levels were greater in muscle and blood compartments and proportions of fast-twitch fibers, whereas levels of mitochondrial superoxide dismutase (SOD) and Trolox equivalent antioxidant capacity (TEAC) decreased. In severe COPD, nitrosative stress and reduced antioxidant capacity were demonstrated in vastus lateralis and systemic compartments of iron-deficient patients. The slow- to fast-twitch muscle fiber switch towards a less resistant phenotype was significantly more prominent in muscles of these patients. Iron deficiency is associated with a specific pattern of nitrosative and oxidative stress and reduced antioxidant capacity in severe COPD irrespective of quadriceps muscle function. In clinical settings, parameters of iron metabolism and content should be routinely quantify given its implications in redox balance and exercise tolerance.
Open AccessNitrosative and Oxidative Stress, Reduced Antioxidant Capacity, and Fiber Type Switch in Iron-Deficient COPD Patients: Analysis of Muscle and Systemic Compartments
We hypothesized that a rise in the levels of oxidative/nitrosative stress markers and a decline in antioxidants might take place in systemic and muscle compartments of chronic obstructive pulmonary disease (COPD) patients with non-anemic iron deficiency. In COPD patients with/without iron depletion (n = 20/group), markers of oxidative/nitrosative stress and antioxidants were determined in blood and vastus lateralis (biopsies, muscle fiber phenotype). Iron metabolism, exercise, and limb muscle strength were assessed in all patients. In iron-deficient COPD compared to non-iron deficient patients, oxidative (lipofuscin) and nitrosative stress levels were greater in muscle and blood compartments and proportions of fast-twitch fibers, whereas levels of mitochondrial superoxide dismutase (SOD) and Trolox equivalent antioxidant capacity (TEAC) decreased. In severe COPD, nitrosative stress and reduced antioxidant capacity were demonstrated in vastus lateralis and systemic compartments of iron-deficient patients. The slow- to fast-twitch muscle fiber switch towards a less resistant phenotype was significantly more prominent in muscles of these patients. Iron deficiency is associated with a specific pattern of nitrosative and oxidative stress and reduced antioxidant capacity in severe COPD irrespective of quadriceps muscle function. In clinical settings, parameters of iron metabolism and content should be routinely quantify given its implications in redox balance and exercise tolerance.
- 1 October 2022
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 58 (10) , 689-698
Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial
- 1 October 2022
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 58 (10) , 689-698
Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial
- Open Access
Iron Depletion in Systemic and Muscle Compartments Defines a Specific Phenotype of Severe COPD in Female and Male Patients: Implications in Exercise Tolerance
We hypothesized that iron content and regulatory factors, which may be involved in exercise tolerance, are differentially expressed in systemic and muscle compartments in iron deficient severe chronic obstructive pulmonary disease (COPD) patients. In the vastus lateralis and blood of severe COPD patients with/without iron depletion, iron content and regulators, exercise capacity, and muscle function were evaluated in 40 severe COPD patients: non-iron deficiency (NID) and iron deficiency (ID) (20 patients/group). In ID compared to NID patients, exercise capacity, muscle iron and ferritin content, serum transferrin saturation, hepcidin-25, and hemojuvelin decreased, while serum transferrin and soluble transferrin receptor and muscle IRP-1 and IRP-2 increased. Among all COPD, a significant positive correlation was detected between FEV1 and serum transferrin saturation. In ID patients, significant positive correlations were detected between serum ferritin, hepcidin, and muscle iron content and exercise tolerance and between muscle IRP-2 and serum ferritin and hepcidin levels. In ID severe COPD patients, iron content and its regulators are differentially expressed. A potential crosstalk between systemic and muscle compartments was observed in the ID patients. Lung function and exercise capacity were associated with several markers of iron metabolism regulation. Iron status should be included in the overall assessment of COPD patients given its implications in their exercise performance.
Open AccessIron Depletion in Systemic and Muscle Compartments Defines a Specific Phenotype of Severe COPD in Female and Male Patients: Implications in Exercise Tolerance
We hypothesized that iron content and regulatory factors, which may be involved in exercise tolerance, are differentially expressed in systemic and muscle compartments in iron deficient severe chronic obstructive pulmonary disease (COPD) patients. In the vastus lateralis and blood of severe COPD patients with/without iron depletion, iron content and regulators, exercise capacity, and muscle function were evaluated in 40 severe COPD patients: non-iron deficiency (NID) and iron deficiency (ID) (20 patients/group). In ID compared to NID patients, exercise capacity, muscle iron and ferritin content, serum transferrin saturation, hepcidin-25, and hemojuvelin decreased, while serum transferrin and soluble transferrin receptor and muscle IRP-1 and IRP-2 increased. Among all COPD, a significant positive correlation was detected between FEV1 and serum transferrin saturation. In ID patients, significant positive correlations were detected between serum ferritin, hepcidin, and muscle iron content and exercise tolerance and between muscle IRP-2 and serum ferritin and hepcidin levels. In ID severe COPD patients, iron content and its regulators are differentially expressed. A potential crosstalk between systemic and muscle compartments was observed in the ID patients. Lung function and exercise capacity were associated with several markers of iron metabolism regulation. Iron status should be included in the overall assessment of COPD patients given its implications in their exercise performance.
- 4 September 2022
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 60 (suppl 66)
Imaging analysis of sarcopenia in a cohort of stable patients with bronchiectasis
Introduction: Chronic respiratory diseases are associated with systemic manifestations, characterized by alterations in the different body compartments. Sarcopenia, defined as loss of function and/or muscle mass, is present in diseases such as bronchiectasis (BQ). Our objective was to characterize by imaging (ultrasound and MRI) the degree of sarcopenia in the quadriceps of stable patients with non-fibrotic BQ. Methods: In stable adult patients (n=20) with BQ and sarcopenia: fat free mass (FFMI) < 16 kg/m2 (men) and < 15 kg/m2 (women) and ratio of quadriceps strength (QMVC) to fat free mass (QMVC/FFM) < 0.8 and in healthy control subjects (n=10) the architecture and composition of the vastus lateralis (VL) of the non-dominant quadriceps was evaluated in a cross-sectional and prospective study. Results: Compared to control subjects, patients had mild airflow obstruction, reduced upper and lower extremity muscle strength and body mass index, with no nutritional alterations. Imaging tests showed decreased muscle thickness and pennation angle, while fatty infiltration and edema were increased. Quadriceps strength was positively correlated with exercise capacity and LV muscle area, while negative correlations were observed between age and the variables quadriceps strength, exercise, LV elasticity. Conclusions: These data demonstrate the presence of radiological alterations in the quadriceps of stable patients with bronchiectasis and sarcopenia without nutritional alterations. These results have clinical implications for exercise training programs in patients with bronchiectasis. Funding: FIS 21/00215 (FEDER, ISC-III), Intensification INT19, CIBERES (ISC-III), and SEPAR 2020 Research Grants.
- 4 September 2022
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 60 (suppl 66)
Imaging analysis of sarcopenia in a cohort of stable patients with bronchiectasis
Introduction: Chronic respiratory diseases are associated with systemic manifestations, characterized by alterations in the different body compartments. Sarcopenia, defined as loss of function and/or muscle mass, is present in diseases such as bronchiectasis (BQ). Our objective was to characterize by imaging (ultrasound and MRI) the degree of sarcopenia in the quadriceps of stable patients with non-fibrotic BQ. Methods: In stable adult patients (n=20) with BQ and sarcopenia: fat free mass (FFMI) < 16 kg/m2 (men) and < 15 kg/m2 (women) and ratio of quadriceps strength (QMVC) to fat free mass (QMVC/FFM) < 0.8 and in healthy control subjects (n=10) the architecture and composition of the vastus lateralis (VL) of the non-dominant quadriceps was evaluated in a cross-sectional and prospective study. Results: Compared to control subjects, patients had mild airflow obstruction, reduced upper and lower extremity muscle strength and body mass index, with no nutritional alterations. Imaging tests showed decreased muscle thickness and pennation angle, while fatty infiltration and edema were increased. Quadriceps strength was positively correlated with exercise capacity and LV muscle area, while negative correlations were observed between age and the variables quadriceps strength, exercise, LV elasticity. Conclusions: These data demonstrate the presence of radiological alterations in the quadriceps of stable patients with bronchiectasis and sarcopenia without nutritional alterations. These results have clinical implications for exercise training programs in patients with bronchiectasis. Funding: FIS 21/00215 (FEDER, ISC-III), Intensification INT19, CIBERES (ISC-III), and SEPAR 2020 Research Grants.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA2075
LOSS OF MUSCLE MASS AND FUNCTION AND NUTRITIONAL ABNORMALITIES IN PATIENTS WITH BRONCHIECTASIS
Background: Muscle dysfunction and nutritional abnormalities are common manifestations in chronic respiratory diseases. Whether patients with non-cystic fibrosis bronchiectasis (NCFB) may experience alterations in muscle mass and performance remains unanswered. Objectives: To assess muscle mass, function, nutritional parameters and exercise tolerance in NCFB patients. Methods: Body weight and composition (muscle mass, bioimpedance), blood nutritional parameters, lung function (spirometry, and diffusion capacity), peripheral and respiratory muscle function and exercise capacity were evaluated in 142 NCFB patients that were prospectively and consecutively recruited in the Bronchiectasis Multidisciplinary Unit at Hospital del Mar (years 2018-2021, Barcelona). Results: One hundred and six female patients were recruited (36 males). All patients had mild-to-moderate airway obstruction, air trapping, and reduced diffusion capacity. Compared to male patients, female patients were older, muscle mass was lower, fatty tissue was greater, creatinine and prealbumin were lower, muscle strength of both upper and lower limbs was significantly reduced, and exercise capacity was decreased. When patients were subdivided according to disease severity (FACED, females and males), patients with greater FACED scores exhibited a significant reduction in body weight, muscle strength (upper and lower extremities), exercise capacity and lung function. Conclusions: Nutritional abnormalities and reduced muscle function are very prominent in female NCFB patients as opposed to males. Moreover, these features were especially present in the more severe patients according to FACED scores. Funding: CIBERES (ISCIII), SEPAR 2020
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA2075
LOSS OF MUSCLE MASS AND FUNCTION AND NUTRITIONAL ABNORMALITIES IN PATIENTS WITH BRONCHIECTASIS
Background: Muscle dysfunction and nutritional abnormalities are common manifestations in chronic respiratory diseases. Whether patients with non-cystic fibrosis bronchiectasis (NCFB) may experience alterations in muscle mass and performance remains unanswered. Objectives: To assess muscle mass, function, nutritional parameters and exercise tolerance in NCFB patients. Methods: Body weight and composition (muscle mass, bioimpedance), blood nutritional parameters, lung function (spirometry, and diffusion capacity), peripheral and respiratory muscle function and exercise capacity were evaluated in 142 NCFB patients that were prospectively and consecutively recruited in the Bronchiectasis Multidisciplinary Unit at Hospital del Mar (years 2018-2021, Barcelona). Results: One hundred and six female patients were recruited (36 males). All patients had mild-to-moderate airway obstruction, air trapping, and reduced diffusion capacity. Compared to male patients, female patients were older, muscle mass was lower, fatty tissue was greater, creatinine and prealbumin were lower, muscle strength of both upper and lower limbs was significantly reduced, and exercise capacity was decreased. When patients were subdivided according to disease severity (FACED, females and males), patients with greater FACED scores exhibited a significant reduction in body weight, muscle strength (upper and lower extremities), exercise capacity and lung function. Conclusions: Nutritional abnormalities and reduced muscle function are very prominent in female NCFB patients as opposed to males. Moreover, these features were especially present in the more severe patients according to FACED scores. Funding: CIBERES (ISCIII), SEPAR 2020
- 1 March 2021
- Published by Elsevier in Respiratory Medicine
- Vol. 178, 106325
Incidence of pulmonary embolism in patients with non-invasive respiratory support during COVID-19 outbreak
- 1 March 2021
- Published by Elsevier in Respiratory Medicine
- Vol. 178, 106325
Incidence of pulmonary embolism in patients with non-invasive respiratory support during COVID-19 outbreak
- Open Access
- 1 January 2021
- Published by Elsevier in Open Respiratory Archives
- Vol. 3 (1) , 100084
¿La función muscular inspiratoria podría ser un equivalente de la insuflación pulmonar en los pacientes con EPOC?
- 1 January 2021
- Published by Elsevier in Open Respiratory Archives
- Vol. 3 (1) , 100084
Open Access¿La función muscular inspiratoria podría ser un equivalente de la insuflación pulmonar en los pacientes con EPOC?